Bvf Inc Kura Oncology, Inc. Transaction History

Bvf Inc

$2.28 Billion
Q1 2025

A detailed history of Bvf Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Bvf Inc holds 7,754,129 shares of KURA stock, worth $50.3 Million. This represents 2.25% of its overall portfolio holdings.

Number of Shares

7,754,129

Previous 2,567,469 202.01%

Holding current value

$50.3 Million

Previous $22.4 Million 128.86%

% of portfolio

2.25%

Previous 0.84%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$6.6 - $9.05 $34.2 Million - $46.9 Million	5,186,660 Added 202.01%	7,754,129 $51.2 Million
Q4 2024 Feb 14, 2025	SELL	$8.51 - $19.21 $6.84 Million - $15.5 Million	-804,292 Reduced 23.85%	2,567,469 $22.4 Million
Q3 2024 Nov 14, 2024	SELL	$18.57 - $23.23 $13.2 Million - $16.5 Million	-710,276 Reduced 17.4%	3,371,761 $65.9 Million
Q2 2024 Aug 14, 2024	SELL	$17.53 - $22.98 $12.3 Million - $16.2 Million	-704,256 Reduced 14.71%	4,082,037 $84 Million
Q1 2024 May 15, 2024	SELL	$13.42 - $23.53 $34.7 Million - $60.9 Million	-2,586,935 Reduced 35.09%	4,786,293 $102 Million
Q4 2023 Feb 14, 2024	BUY	$7.58 - $14.38 $4.87 Million - $9.24 Million	642,245 Added 9.54%	7,373,228 $106 Million
Q1 2023 May 15, 2023	BUY	$10.71 - $14.6 $31.4 Million - $42.8 Million	2,930,000 Added 77.09%	6,730,983 $82.3 Million
Q4 2022 Feb 14, 2023	BUY	$11.23 - $16.9 $6.71 Million - $10.1 Million	597,200 Added 18.64%	3,800,983 $47.2 Million
Q1 2022 May 16, 2022	BUY	$11.78 - $16.98 $13.4 Million - $19.3 Million	1,139,571 Added 55.21%	3,203,783 $51.5 Million
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $5.24 Million - $8.4 Million	429,100 Added 26.24%	2,064,212 $28.9 Million
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $9.63 Million - $15.2 Million	389,200 Added 31.24%	1,635,112 $46.2 Million
Q4 2020 Feb 12, 2021	SELL	$29.0 - $41.62 $7.05 Million - $10.1 Million	-243,200 Reduced 16.33%	1,245,912 $40.7 Million
Q3 2020 Nov 13, 2020	SELL	$16.3 - $30.64 $21 Million - $39.4 Million	-1,286,770 Reduced 46.36%	1,489,112 $45.6 Million
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $2.71 Million - $6.42 Million	341,186 Added 14.01%	2,775,882 $45.2 Million
Q1 2020 May 15, 2020	BUY	$6.45 - $14.04 $2.81 Million - $6.13 Million	436,420 Added 21.84%	2,434,696 $24.2 Million
Q3 2019 Nov 14, 2019	SELL	$14.75 - $20.87 $3.04 Million - $4.3 Million	-205,843 Reduced 9.34%	1,998,276 $30.3 Million
Q2 2019 Aug 14, 2019	SELL	$14.71 - $19.79 $4.28 Million - $5.76 Million	-291,037 Reduced 11.66%	2,204,119 $43.4 Million
Q1 2019 May 15, 2019	SELL	$13.73 - $16.87 $3.84 Million - $4.72 Million	-280,000 Reduced 10.09%	2,495,156 $41.4 Million
Q4 2018 Feb 14, 2019	BUY	$10.6 - $17.49 $8.05 Million - $13.3 Million	759,300 Added 37.67%	2,775,156 $39 Million
Q3 2018 Nov 14, 2018	SELL	$16.65 - $21.85 $690,808 - $906,556	-41,490 Reduced 2.02%	2,015,856 $35.3 Million
Q2 2018 Aug 14, 2018	BUY	$14.8 - $18.8 $10.4 Million - $13.2 Million	703,500 Added 51.96%	2,057,346 $37.4 Million
Q3 2017 Nov 14, 2017	BUY	$6.05 - $14.95 $8.19 Million - $20.2 Million	1,353,846	1,353,846 $20.2 Million

Others Institutions Holding KURA

# of Institutions

190

Shares Held

79M

Call Options Held

76K

Put Options Held

85.8K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $434M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Account